Hyperthyroidism is the most common endocrine disorder in older cats, causing significant welfare impacts if untreated but responding well to several effective treatment options.
Hyperthyroidism management in cats demonstrates how welfare-sensitive medicine can be. The disease itself causes significant suffering - weight loss, chronic nausea, and cardiovascular strain. All effective treatments carry some welfare cost: daily tablets are stressful, radioiodine requires hospitalisation, surgery carries anaesthetic risk. The welfare goal is to achieve effective thyroid control through the method that minimises ongoing suffering while successfully treating the disease. For most cats, radioiodine offers the best long-term welfare outcome with a single treatment. Early diagnosis through regular senior cat health checks maximises the range of treatment options before complications develop.